Weight average (540 47 Kg), estimated by standardized measuring tape around the thorax, and was similar in all groups
After one year, people in the GLP-1 group could walk 13% farther, had more pain-free walking, had lower blood sugar, and lost more weight than people in the placebo group
Relative contraindications and special populations requiring careful consideration: Patients with severe hepatic impairment (Child-Pugh class C) should generally avoid these medications due to insufficient safety data
Ongoing: your physician adjusts your dose as your body adapts
, , May 30, 2025 smotrim.top
We would be happy to sit down and talk to you about your cosmetic options and answer any questions that you may have